Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Mar-24 4:17 PM View:  | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 12-Mar-24 | Payment of Exercise | 30,790 | $5.31 | $163,495.00 | (6%) 558.11K to 527.32K | |
| 14-Mar-24 4:17 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 12-Mar-24 | Option Exercise | 87,720 | -- | -- | 19% 470.39K to 558.11K | |
| 05-Mar-24 4:40 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Payment of Exercise | 44,562 | $5.47 | $243,754.00 | (12%) 363.94K to 319.38K | |
| 05-Mar-24 4:40 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Option Exercise | 88,945 | -- | -- | 32% 275.0K to 363.94K | |
| 05-Mar-24 4:54 PM View: | Daly Jason B. SVP, Chief Legal Officer | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Option Exercise | 60,871 | -- | -- | 420% 14.48K to 75.35K | |
| 05-Mar-24 4:56 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Payment of Exercise | 36,023 | $5.47 | $197,046.00 | (7%) 506.41K to 470.39K | |
| 05-Mar-24 4:35 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Payment of Exercise | 41,135 | $5.47 | $225,008.00 | (10%) 432.8K to 391.67K | |
| 05-Mar-24 4:35 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Option Exercise | 82,103 | -- | -- | 23% 350.7K to 432.8K | |
| 05-Mar-24 4:54 PM View: | Daly Jason B. SVP, Chief Legal Officer | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Payment of Exercise | 18,030 | $5.47 | $98,624.10 | (24%) 75.35K to 57.32K | |
| 05-Mar-24 4:56 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-24 | Option Exercise | 102,629 | -- | -- | 25% 403.78K to 506.41K | |
| 05-Mar-24 4:35 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Payment of Exercise | 15,181 | $5.47 | $83,040.10 | (4%) 365.88K to 350.7K | |
| 05-Mar-24 4:35 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Option Exercise | 28,957 | -- | -- | 9% 336.92K to 365.88K | |
| 05-Mar-24 4:56 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Option Exercise | 36,197 | -- | -- | 10% 380.84K to 417.04K | |
| 05-Mar-24 4:40 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Payment of Exercise | 16,219 | $5.47 | $88,717.90 | (6%) 291.22K to 275.0K | |
| 05-Mar-24 4:40 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Option Exercise | 31,371 | -- | -- | 12% 259.85K to 291.22K | |
| 05-Mar-24 4:56 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-24 | Payment of Exercise | 13,257 | $5.47 | $72,515.80 | (3%) 417.04K to 403.78K | |
| 29-Feb-24 4:26 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 27-Feb-24 | Payment of Exercise | 16,556 | $5.71 | $94,534.80 | (6%) 276.4K to 259.85K | |
| 29-Feb-24 4:26 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 27-Feb-24 | Option Exercise | 31,663 | -- | -- | 13% 244.74K to 276.4K | |
| 29-Feb-24 4:25 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 27-Feb-24 | Payment of Exercise | 18,670 | $5.71 | $106,606.00 | (5%) 355.59K to 336.92K | |
| 29-Feb-24 4:25 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 27-Feb-24 | Option Exercise | 35,620 | -- | -- | 11% 319.97K to 355.59K | |
| 03-Jan-24 4:36 PM View: | Patel Gautam Director | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Jan-24 | Gift | 1,598,120 | -- | -- | 5% 33.83M to 35.43M | |
| 03-Jan-24 4:36 PM View: | Patel Gautam Director | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Jan-24 | Disposition (other) | 33,458,100 | -- | -- | (94%) 35.43M to 1.97M | |
| 08-Nov-23 6:20 PM View: | Patel Chirag K. President & Co-CEO Director | Amneal Pharmaceuticals, Inc. (AMRX) | 07-Nov-23 | Acquisition (other) | 21,269,400 | -- | -- | 4150% 512.6K to 21.78M | |
| 08-Nov-23 6:22 PM View: | Patel Tushar Bhikhubhai 10% Owner | Amneal Pharmaceuticals, Inc. (AMRX) | 07-Nov-23 | Acquisition (other) | 53,578,200 | -- | -- | 100% 0 to 53.58M | |
| 08-Nov-23 6:21 PM View: | Patel Dipan | Amneal Pharmaceuticals, Inc. (AMRX) | 07-Nov-23 | Acquisition (other) | 26,905,100 | -- | -- | 100% 0 to 26.91M | |
| 08-Nov-23 6:20 PM View: | Patel Chintu Co-CEO Director | Amneal Pharmaceuticals, Inc. (AMRX) | 07-Nov-23 | Acquisition (other) | 24,753,300 | -- | -- | 4829% 512.5K to 25.27M | |
| 08-Nov-23 6:21 PM View: | Patel Gautam Director 10% Owner | Amneal Pharmaceuticals, Inc. (AMRX) | 07-Nov-23 | Acquisition (other) | 17,497,300 | -- | -- | 132% 13.26M to 30.76M | |
| 15-Aug-23 4:30 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 11-Aug-23 | Market Sale | 29,302 | $4.13 | $120,921.00 | (11%) 274.04K to 244.74K | (14%) |
| 01-Aug-23 4:30 PM View: | Autor Deborah M. Director | Amneal Pharmaceuticals, Inc. (AMRX) | 30-Jul-23 | Option Exercise | 54,949 | -- | -- | 100% 0 to 54.95K | |
| 05-Jul-23 4:30 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 30-Jun-23 | Payment of Exercise | 11,571 | $3.10 | $35,870.10 | (4%) 285.61K to 274.04K | |
| 05-Jul-23 4:30 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 30-Jun-23 | Option Exercise | 23,095 | -- | -- | 9% 262.52K to 285.61K | |
| 11-May-23 4:15 PM View: | Alva Emily Peterson Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 85% 94.19K to 174.32K | |
| 11-May-23 4:15 PM View: | Nark Ted C Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 56% 144.19K to 224.32K | |
| 11-May-23 4:15 PM View: | Patel Gautam Director 10% Owner | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | < 1% 13.18M to 13.26M | |
| 11-May-23 4:15 PM View: | Yanai Shlomo Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 90% 89.15K to 169.27K | |
| 11-May-23 4:15 PM View: | George Jeffrey P. Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 71% 112.96K to 193.08K | |
| 11-May-23 4:15 PM View: | Buchi J Kevin Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 76% 105.49K to 185.62K | |
| 11-May-23 4:15 PM View: | Meister Paul M Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 112,179 | -- | -- | 22% 508.48K to 620.66K | |
| 11-May-23 4:15 PM View: | Kiely John Director | Amneal Pharmaceuticals, Inc. (AMRX) | 10-May-23 | Option Exercise | 80,128 | -- | -- | 81% 99.15K to 179.27K | |
| 14-Mar-23 4:30 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 12-Mar-23 | Option Exercise | 87,719 | -- | -- | 30% 293.12K to 380.84K | |
| 07-Mar-23 6:00 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Option Exercise | 39,251 | -- | -- | 16% 242.95K to 282.2K | |
| 07-Mar-23 6:00 PM View: | Daly Jason B. SVP, Chief Legal Officer | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Payment of Exercise | 8,164 | $1.92 | $15,674.90 | (36%) 22.64K to 14.48K | |
| 07-Mar-23 6:00 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Option Exercise | 45,289 | -- | -- | 18% 247.83K to 293.12K | |
| 07-Mar-23 6:00 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Payment of Exercise | 19,685 | $1.92 | $37,795.20 | (7%) 282.2K to 262.52K | |
| 07-Mar-23 6:00 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Option Exercise | 36,232 | -- | -- | 12% 301.8K to 338.04K | |
| 07-Mar-23 6:00 PM View: | Daly Jason B. SVP, Chief Legal Officer | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Option Exercise | 22,645 | -- | -- | 100% 0 to 22.64K | |
| 07-Mar-23 6:00 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 03-Mar-23 | Payment of Exercise | 18,064 | $1.92 | $34,682.90 | (5%) 338.04K to 319.97K | |
| 03-Mar-23 4:31 PM View: | Shah Nikita Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-23 | Payment of Exercise | 22,059 | $2.09 | $46,103.30 | (7%) 323.86K to 301.8K | |
| 03-Mar-23 4:31 PM View: | Boyer Andrew S Executive Vice President | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-23 | Option Exercise | 43,717 | -- | -- | 20% 222.2K to 265.92K | |
| 03-Mar-23 4:30 PM View: | Konidaris Tasos Executive Vice President & CFO | Amneal Pharmaceuticals, Inc. (AMRX) | 01-Mar-23 | Option Exercise | 36,197 | -- | -- | 17% 211.63K to 247.83K |
